These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25742747)

  • 1. An integrative approach identified genes associated with drug response in gastric cancer.
    Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK
    Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
    Pan HX; Bai HS; Guo Y; Cheng ZY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancer.
    Ohmura H; Ito M; Uchino K; Okada C; Tanishima S; Yamada Y; Momosaki S; Komoda M; Kuwayama M; Yamaguchi K; Okumura Y; Nakano M; Tsuchihashi K; Isobe T; Ariyama H; Kusaba H; Oda Y; Akashi K; Baba E
    FEBS Open Bio; 2020 Jan; 10(1):147-157. PubMed ID: 31736281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
    Hu C; Zhou Y; Liu C; Kang Y
    Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells.
    Yuan G; Regel I; Lian F; Friedrich T; Hitkova I; Hofheinz RD; Ströbel P; Langer R; Keller G; Röcken C; Zimmermann W; Schmid RM; Ebert MP; Burgermeister E
    Oncogene; 2013 Jan; 32(3):375-87. PubMed ID: 22370641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
    Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
    Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
    Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of fumarate hydratase activity increases the efficacy of cisplatin-mediated chemotherapy in gastric cancer.
    Yu HE; Wang F; Yu F; Zeng ZL; Wang Y; Lu YX; Jin Y; Wang DS; Qiu MZ; Pu HY; Kang TB; Xie D; Ju HQ; Xu RH; Luo HY
    Cell Death Dis; 2019 May; 10(6):413. PubMed ID: 31138787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
    Yu J; Li L; Huang C
    Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs.
    Nogales V; Reinhold WC; Varma S; Martinez-Cardus A; Moutinho C; Moran S; Heyn H; Sebio A; Barnadas A; Pommier Y; Esteller M
    Oncotarget; 2016 Jan; 7(3):3084-97. PubMed ID: 26625211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway.
    Eto K; Iwatsuki M; Watanabe M; Ishimoto T; Ida S; Imamura Y; Iwagami S; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Int J Cancer; 2015 Apr; 136(7):1537-45. PubMed ID: 25159729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ING5 suppresses proliferation, apoptosis, migration and invasion, and induces autophagy and differentiation of gastric cancer cells: a good marker for carcinogenesis and subsequent progression.
    Gou WF; Shen DF; Yang XF; Zhao S; Liu YP; Sun HZ; Su RJ; Luo JS; Zheng HC
    Oncotarget; 2015 Aug; 6(23):19552-79. PubMed ID: 25980581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
    Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated PITX1 Modulated by MiR-19a-3p Promotes Cell Malignancy and Predicts a Poor Prognosis of Gastric Cancer by Affecting Transcriptionally Activated PDCD5.
    Qiao F; Gong P; Song Y; Shen X; Su X; Li Y; Wu H; Zhao Z; Fan H
    Cell Physiol Biochem; 2018; 46(6):2215-2231. PubMed ID: 29734189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.